[Federal Register Volume 69, Number 50 (Monday, March 15, 2004)]
[Notices]
[Page 12178]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-5774]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 18, 2004, Johnson 
Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, 
West Deptford, New Jersey 08066, made application by letter to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of Methamphetamine (1105), and Hydromorphone (9150), basic 
class of controlled substances listed in Schedule II. The firm had 
inadvertently dropped the two basic classes from its renewal 
application submitted on August 25, 2003, and published in the Federal 
Register on February 18, 2004 (69 FR 7656).
    The firm plans to manufacture the listed controlled substances in 
bulk to supply to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than May 14, 
2004.

    Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-5774 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M